Prenatal diagnosis in maternal plasma of a fetal mutation causing propionic acidemia

Molecular Genetics and Metabolism

Volumn 95, Issue 1-2, 2008, Pages 101-103

  Bustamante Aragones, Ana ^a   Pérez Cerdá, Celia ^b   Pérez, Belén ^b   Rodriguez de Alba, Marta ^a   Ugarte, Magdalena ^b   Ramos, Carmen ^a  

^a CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED DE ENFERMEDADES RARAS CIBERER   (Spain)

^b Centro de diagnóstico de enfermedades moleculares   (Spain)

Author keywords

Fetal DNA; Maternal plasma; Non invasive prenatal diagnosis; Propionic acidemia

Indexed keywords

DNA;

ARTICLE; FETUS; GENE MUTATION; GESTATIONAL AGE; HUMAN; MATERNAL BLOOD; MATERNAL PLASMA; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; PROPIONIC ACIDEMIA; RISK FACTOR; SPONTANEOUS ABORTION;

AMINO ACID METABOLISM, INBORN ERRORS; FEMALE; FETAL DISEASES; GENETIC SCREENING; HUMANS; MALE; METHYLMALONYL-COA DECARBOXYLASE; MUTATION; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PRENATAL DIAGNOSIS;

EID: 51849091407     PISSN: 10967192     EISSN: 10967206     Source Type: Journal    
DOI: 10.1016/j.ymgme.2008.05.006     Document Type: Article

References (10)

1. Desviat L.R., Pérez B., Pérez-Cerda C., RodríguezPombo P., Clavero S., and Prema G. Propionic acidemia: mutation update and functional and structural effects of the variant alleles. Mol. Genet. Metab. 83 (2004) 28-37
2. Perez-Cerda C., Perez B., Merinero B., Desviat L.R., Rodriguez Pombo P., and Prema G. Prenatal diagnosis of propionic academia. Prenat. Diagn. 24 (2004) 962-964
3. Muro S., Pérez-Cerda C., Rodríguez-Pombo P., Pérez B., Briones P., Ribes A., and Ugarte M. Feasibility of DNA based methods for prenatal diagnosis and carrier detection of propionic acidaemia. J. Med. Genet. 36 (1999) 412-414
4. Lo Y.M., Corbetta N., Chamberlain P.F., Rai V., Sargent I.L., Redman C.W., and Wainscoat J.S. Presence of fetal DNA in maternal plasma and serum. Lancet 350 (1997) 485-487
5. Lo Y.M., Tein M.S., Lau T.K., Haines C.J., Leung T.N., Poon P.M., Wainscoat J.S., Johnson P.J., Chang A.M., and Hjelm N.M. Quantitative analysis of fetal DNA in maternal plasma and serum: implications for noninvasive prenatal diagnosis. Am. J. Hum. Genet. 62 (1998) 768-775
6. Bustamante-Aragones A., Rodríguez de Alba M., Gonzalez-Gonzalez C., Trujillo-Tiebas M.J., Diego-Alvarez D., Vallespin E., Plaza J., Ayuso C., and Ramos C. Fetal sex determination in maternal blood from the 7th week of gestation and its role in diagnosing haemophilia in the fetuses of female carriers. Haemophilia 14 (2008) 593-598
7. Gautier E., Benachi A., Giovangrandi Y., Ernault P., Olivi M., Gaillon T., and Costa J.M. Fetal RhD genotyping by maternal serum analysis: a two-year experience. Am. J. Obstet. Gynecol. 192 (2005) 666-669
8. Saito H., Sekizawa A., Morimoto T., Suzuki M., and Yanaihara T. Prenatal DNA diagnosis of a single-gene disorder from maternal plasma. Lancet 30 356 (2000) 1170
9. Gonzalez-Gonzalez M.C., Garcia-Hoyos M., Trujillo M.J., Rodríguez de Alba M., Lorda-Sánchez I., Díaz-Recasens J., Gallardo E., Ayuso C., and Ramos C. Prenatal detection of a cystic fibrosis mutation in fetal DNA from maternal plasma. Prenat. Diagn. 22 (2002) 946-948
10. Bustamante-Aragones A., Gallego-Merlo J., Trujillo-Tiebas M.J., Rodríguez de Alba M., Gonzalez-Gonzalez C., Glover G., Diego-Alvarez D., Ayuso C., and Ramos C. New strategy for the prenatal detection/exclusion of paternal cystic fibrosis mutations in maternal plasma. J. Cyst. Fibros. (2008) 10.1016/j.jcf.2008.05.006